Hot Stocks: 3 stocks that may give returns between 13-43%

ET BureauLast Updated: Apr 25, 2025, 05:58:00 AM IST

Synopsis

Analysts predict significant upside for select stocks, with potential returns ranging from 13% to 43%. Divi's Laboratories is poised to benefit from its involvement in diabetes and weight loss drugs. Devyani International's acquisition of Sky Gate Hospitality is expected to boost its QSR business, while Anant Raj's data center plans drive its growth despite revised timelines.

A look at some of the latest stock recommendations by analysts. These stocks are expected to return between 13% and 43% as per analyst price targets.

DIVI’S LABORATORIES

BROKERAGE: CITI Price Target: Rs 7,050 CMP: Rs 6,216 | Upside: 13%

• Orforglipron, Eli Lilly’s oral diabetes drug, next addition in Divi’s pipeline
• Potential to become primary supplier Company has announced $170-million capex, which Citi believes is primarily for GLP-1—medication to manage
• Type 2 diabetes and obesity Divi’s could be a key player for Eli Lilly’s next weight loss product—Retatrutide

DEVYANI INTERNATIONAL
BROKERAGE: BERNSTEIN Price Target: Rs 220 CMP: Rs 179 | Upside: 23%

• Reiterate positive view after acquiring majority stake in unlisted Sky Gate Hospitality, which owns Biryani By Kilo and other cloud kitchens
• Value accretive for Devyani as deal done at 2-2.5 times sales
• QSR (Quick Service Restaurant) chains at 4-6.6 times sales FY25 and FY26 earnings to be volatile because of M&A and growth moves

ANANT RAJ
BROKERAGE: NOMURA Price Target: Rs 700 CMP: Rs 488 | Upside: 43%

• Reiterate Buy rating but cut price target from Rs 750 to Rs 700 citing a more conservative stance on its data centre unit
• Company’s 307 Mega Watt Data Centre target will be reached by FY32-33 as against earlier expectations of FY31
• Valuations still attractive as earnings per share estimated to grow over 40% on a compounded basis over FY26-27

...moreless

...moreless